• HOME
  • Search & Results
  • Full Text
  • Thesis Details
 
Page: 211
 
Full Screen

  • TITLE
  • CERTIFICATE
  • DECLARATION
  • ACKNOWLEDGEMENT
  • CONTENTS
  • LIST OF PATENTS /PUBLICATIONS AND CONFERENCE PROCEEDINGS
  • ABSTRACT
  • I. Tuning of Borane Reagents for Selective Carboxylate and Related Carbonyl Reductions
  • I.1 Background and Scope of the Thesis
  • I.1.1 Introduction
  • I.1.2 (2S, 3S) and (2S, 3R) - Tetrahydro-3-hydroxy-5-oxo-2, 3-furandicarboxylic acids (1 & 2)
  • I.1.3 Chirons obtained from (2S, 3S) and (2S, 3R) - tetrahydro-3-hydroxy-5-oxo-2, 3-furandicarboxylic acid
  • I.2 Tuning of Borane Reagents for Selective Carboxylate and Related Carbonyl Reductions: a Review
  • I.2.1 Directed Borane and Borohydride reductions
  • I.2.2 Selective reduction of Carboxylic acids
  • I.2.3 Selective reduction of Ester and Lactone Carboxylate
  • I.2.4 Selective reduction of Carboxylates in presence of reducible groups like -NO2, -CN and Halogens
  • I.2.5 Selective reduction of Arnides / lmides
  • I.2.6 Selective reduction of Anhydrides
  • I.3 Conclusions
  • II. Synthesis of Biologically Significant Chiral Bis Lactone Skeleton
  • II.1 Biologically active γ-butyrolactones and bislactones
  • Il.1.1 Avenaciolide and related bislactones
  • II.1.2 Canadensolide and related bislactones
  • II.1.3 Cis and Trans Whisky and Cognac lactones
  • II.1.4 Funebrine & Funebral
  • II.1.5 PLA2 inhibitors Cinatrin C2 and C3
  • II.1.6 Methylenolactocin and Protolichesterinic acid
  • II.2 Synthesis of Avenaciolide
  • II.3 Results and Discussion
  • II.3.1 Isolation of (2S, 3s) -Tetrahydro-3-hydroxy-5-oxo-2, 3furandicarboxylic acid (1)
  • II.3.2 lsolation of (2S, 3R) -Tetrahydro-3-hydroxy-5-oxo-2, 3 furandicarboxylic acid (2)
  • II.3.3 Enantiomeric Purity of (PS, 3S) -Tetrahydro-3-hydroxy-5-oxo-2, 3-furandicarboxylic acid: Analysis by Vibrational Circular Dichroism (VCD)
  • II.3.4 Enantiomeric Purity of (2S, 3R) -Tetrahydro-3-hydroxy-5-oxo-2, 3-furandicarboxylic acid: Analysis by Vibrational Circular Dichroism (VCD)
  • II.3.5 Strategy for the Synthesis of Core Structure of Avenaciolide and Related Molecules
  • II.3.6 Efficient Site Selective Reduction Employing BH3SMe2 and Catalytic NaBH4
  • II.3.7 Limitations of Saitos Reaction
  • II.3.8 Preparation of Dirnethyl (2S, 3S) -tetrahydro-3-hydroxy-5-oxo-2, 3-furandicarboxylates (10)
  • II.3.9 Selective Reduction of Dirnethyl (2S, 3S) -Tetrahydro-3-hydroxy-5-oxo-2, 3-furandicarboxylate
  • II.3.10 Mechanism of Selective Reduction
  • II.3.11 Methyl (2S, 3R) -terahydro-3-acetyloxy-3-acetyloxymethyl-5-oxo- furan-2-carboxylate (219)
  • II.3.12 Synthesis of (3aR, 6aS) -3a-hydroxytetrahydrofuro[3, 4-b] furan-2, 6-dione (221)
  • II.3.13 Applications of Methyl (2S, 3R) -terahydro-3-hydroxy-3-hydroxymethyl-5-oxo-furan-2-carboxylate (206)
  • II.3.14 Selective Reduction of Dimethyl (2S, 3R) -Tetrahydro-3-Hydroxy-5-oxo-2, 3-furandicarboxyiate (14)
  • II.3.1 5 Methyl (2S, 3S) -terahydro-3-acetyloxy-3-[ (acetyloxy) methyl]-5-oxo-furan-2-carboxylate and Methyl (2R, 3R) -terahydro-3-acetyloxy-2-[ (acetyloxy) methyl]-5-oxo-furan-3-carboxylate (234 & 235)
  • II.3.16 Conversion of Methyl (2S, 3s) -terahydro-3-hydroxy-3-hydroxymethyl-5-oxo-furan-2-carboxylate to (3aS, 6aS) -3a -hydroxytetrahydrofuro[3, 4-b]furan-2, 6-dione (236)
  • II.4 Conformational analysis of Intermediates (208, 209, 232 & 233)
  • II.4.1 Analysis of 208 and 209
  • II.4.2 1, 3 diaxial interactions
  • II.4.3 Spatial separation of the methyl groups in the side chains at C2, C3 positions
  • II.4.4 Ring strain
  • II.4.5 Dipole moment
  • II.4.6 Boron-oxygen distances
  • II.4.7 Analysis of 232 and 233
  • II.4.8 Conclusions
  • II.5 General Experimental Details
  • II.5.1 Experimental procedures for the theoretical study
  • II.6 Experimental
  • II.6.1 (2S, 3S) -Tetrahydro-3hydroxy-5-oxo-2, 3-furandicarboxylic acid (1)
  • II.6.2 (2S, 3R) -Tetrahydro-3-hydroxy-5-oxo-2, 3-furandicarboxylic acid (2)
  • II.6.3 Dimethyl (2S, 3s) -tetrahydro-3-hydroxy-5-oxo-2, 3-furandicarboxylate (10)
  • II.6.4 Dimethyl (2S, 3R) -tetrahydro-3-hydroxy-5-oxo-2, 3-furandicarboxylate (14)
  • II.6.5 Methyl (25 3R) -terahydro-3-hydroxy-3-hydroxymethyl-5-oxo-furan-2-carboxylate (206)
  • II.6.6 Methyl (2S, 3R) -terahydro-3-acetyloxy-3-acetyloxymethyl-5-oxo-furan-2-carboxylate (220)
  • II.6.7 (3aR, 6aS) -3a-hydroxytetrahydrofuro[3, 4-b]furan-2, 6-dione (221)
  • II.6.8 Methyl (2S, 3S) -terahydro-3-acetyloxy-3-[ (acetyloxy) methyl]-5-oxo-furan-2-carboxylate and Methyl (2R, 3R) -terahydro-3-acetyloxy-2-[ (acetyloxy) methyl]-5-oxo-furan-3-carboxylate (234 & 235)
  • III. Chiral Functionalized Butenolides from (2S, 3s) -Tetrahydro-3-hydroxy-5-OxO-2, 3-furandicarboxylic acid
  • III.1 Introduction
  • III.2 Results and Discussion
  • III.2.1 Preparation of Dialkyl (2S, 3s) -tetrahydro-3-hydroxy-5-oxo-2, 3-furandicarboxylates (11-1 3)
  • III.2.2 Preparation of Chiral Butenolides from Dialkyl (2S, 3S) -tetrahydro-3-hydroxy-5-oxo-2, 3-furandicarboxylates (265-267)
  • III.2.3 Preparation of Chiral Butenolide from Diisopropyl (2S, 3S) -tetrahydro-3-hydroxy-5-oxo-2, 3-furandicarboxylates (269)
  • III.3 Experimental
  • III.3.1 Disodium (2S, 3S) -tetrahydro-3-hydroxy-5-oxo-2, 3-furandicarboxylate (6)
  • III.3.2 Diethyl (2S, 3S) -tetrahydro-3-hydroxy-5-oxo-2, 3-furandicarboxylate (11)
  • III.3.3 Diisopropyl (2S, 3S) -tetrahydro-3-hydroxy-5-oxo-2, 3-furandicarboxylate (12)
  • III.3.4 Dibenzyl (2S, 3S) -tetrahydro-3-hydroxy-5-oxo-2, 3-furandicarboxylate (13)
  • III.3.5 Dimethyl 3-methoxy 2 (5H) furanone 4, 5 dicarboxyiate (265)
  • III.3.6 Diethyl 3-methoxy 2 (5H) furanone 4, 5 dicarboxylate (266)
  • III.3.7 Dibenzyl 3-methoxy 2- (5H) furanone 4, 5-dicarboxylate (267)
  • III.3.8 Diisopropyl 3-methoxy- 2- (5H) furanone 4, 5- dicarboxylate (269)
  • IV. Synthesis of Enantiomerically pure Trialkyl (1S, 2S) and (I S, 2R) -1, 2-dihydroxy-l, 2, 3-propanetricarboxylates and Their Application in Asymmetric Catalysis
  • IV.1 introduction
  • IV.1.1 Synthetic Applications of 1, 2 diols
  • IV.2 Results and Discussion
  • IV.2.1 Asymmetric Epoxidation Employing Novel Trialkyl (1S, 2R) and (1S, 2R) -1, 2-dihydroxy-1, 2, 3-propanetricarboxylates
  • IV.2.2 Mechanism of Sharpless Asymmetric Epoxidation reaction
  • IV.2.3 Asymmetric Oxidation of Sulphides to Sulphoxides Employing novel Trialkyl (1S, 2S) and (1S, 2R) -1, 2-dihydroxy-1, 2, 3-propanetricarboxylates
  • IV.2.4 Mechanistic explanation for Enantioselective Sulfoxidation
  • IV.3 Experimental
  • IV.3.1 Trisodium (1S, 2S) -1, 2-dihydroxy-1, 2, 3-propanetricarboxylate (18)
  • IV.3.2 Trimethyl (1S, 2S) -1, 2-dihydroxy-1, 2, 3-propanetricarboxylate (20)
  • IV.3.3 Triethyl (1S, 2S) -1, 2 dihydroxy-1, 2, 3-propanetricarboxylate (21)
  • IV.3.4 Triisopropyl (1S, 2S) -1, 2 dihydroxy-1, 2, 3-propanetricarboxylate (22)
  • IV.3.5 Trisodium (1S, 2R) -1, 2-dihydroxy-1, 2, 3-propanetricarboxylate (19)
  • IV.3.6 Trimethyl (1S, 2R) -1, 2-dihydroxy-1, 2, 3-propanetricarboxylate (23)
  • IV.3.7 Triethyl (1S, 2R) -1, 2 dihydroxy-1, 2, 3-propanetricarboxylate (24)
  • IV.3.8 Triisopropyl (1S, 2R) -1, 2 dihydroxy-1, 2, 3propanetricarboxylate (25)
  • IV.3.9 Epoxygeraniol (276) Employing (20) as chiral ligand
  • lV.3.10 Methyl p-tolyl sulphoxide (290) (Employing as (20) chiral ligand)
  • V. Summary of the Thesis
  • References